» Articles » PMID: 23656734

Proteolytic Activation Transforms Heparin Cofactor II into a Host Defense Molecule

Overview
Journal J Immunol
Date 2013 May 10
PMID 23656734
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

The abundant serine proteinase inhibitor heparin cofactor II (HCII) has been proposed to inhibit extravascular thrombin. However, the exact physiological role of this plasma protein remains enigmatic. In this study, we demonstrate a previously unknown role for HCII in host defense. Proteolytic cleavage of the molecule induced a conformational change, thereby inducing endotoxin-binding and antimicrobial properties. Analyses employing representative peptide epitopes mapped these effects to helices A and D. Mice deficient in HCII showed increased susceptibility to invasive infection by Pseudomonas aeruginosa, along with a significantly increased cytokine response. Correspondingly, decreased levels of HCII were observed in wild-type animals challenged with bacteria or endotoxin. In humans, proteolytically cleaved HCII forms were detected during wounding and in association with bacteria. Thus, the protease-induced uncovering of cryptic epitopes in HCII, which transforms the molecule into a host defense factor, represents a previously unknown regulatory mechanism in HCII biology and innate immunity.

Citing Articles

Clinical Trial Subgroup Analyses to Investigate Clinical and Immunological Outcomes of Convalescent Plasma Therapy in Severe COVID-19.

Raychaudhuri D, Bandopadhyay P, DRozario R, Sarif J, Ray Y, Paul S Mayo Clin Proc Innov Qual Outcomes. 2022; 6(6):511-524.

PMID: 36117954 PMC: 9472644. DOI: 10.1016/j.mayocpiqo.2022.09.001.


Predictive value of proteomic markers for advanced rectal cancer with neoadjuvant chemoradiotherapy.

Wang H, Ji D, Tian H, Gao Z, Song C, Jia J BMC Cancer. 2022; 22(1):868.

PMID: 35945555 PMC: 9361520. DOI: 10.1186/s12885-022-09960-z.


Zone of Interaction Between the Parasite and the Host: Protein Profile of the Body Cavity Fluid of Gasterosteus aculeatus L. Infected with the Cestode Schistocephalus solidus (Muller, 1776).

Kochneva A, Borvinskaya E, Smirnov L Acta Parasitol. 2021; 66(2):569-583.

PMID: 33387269 DOI: 10.1007/s11686-020-00318-8.


System-wide molecular dynamics of endothelial dysfunction in Gram-negative sepsis.

Gallart-Palau X, Serra A, Sze S BMC Biol. 2020; 18(1):175.

PMID: 33234129 PMC: 7687804. DOI: 10.1186/s12915-020-00914-0.


Antithrombin: An anticoagulant, anti-inflammatory and antibacterial serpin.

Rezaie A, Giri H J Thromb Haemost. 2020; 18(3):528-533.

PMID: 32112532 PMC: 7080319. DOI: 10.1111/jth.14724.


References
1.
Garcia-Montoya I, Cendon T, Arevalo-Gallegos S, Rascon-Cruz Q . Lactoferrin a multiple bioactive protein: an overview. Biochim Biophys Acta. 2011; 1820(3):226-36. PMC: 7127262. DOI: 10.1016/j.bbagen.2011.06.018. View

2.
Villa P, Aznar J, Vaya A, Espana F, Ferrando F, Mira Y . Hereditary homozygous heparin cofactor II deficiency and the risk of developing venous thrombosis. Thromb Haemost. 1999; 82(3):1011-4. View

3.
Hoffman M, Pratt C, Brown R, Church F . Heparin cofactor II-proteinase reaction products exhibit neutrophil chemoattractant activity. Blood. 1989; 73(6):1682-5. View

4.
Papareddy P, Rydengard V, Pasupuleti M, Walse B, Morgelin M, Chalupka A . Proteolysis of human thrombin generates novel host defense peptides. PLoS Pathog. 2010; 6(4):e1000857. PMC: 2858699. DOI: 10.1371/journal.ppat.1000857. View

5.
Tollefsen D . Vascular dermatan sulfate and heparin cofactor II. Prog Mol Biol Transl Sci. 2010; 93:351-72. DOI: 10.1016/S1877-1173(10)93015-9. View